首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Metabolic engineering communications

缩写:

ISSN:2214-0301

e-ISSN:2214-0301

IF/分区:4.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引267
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
St Elmo Wilken,Susanna Seppälä,Thomas S Lankiewicz et al. St Elmo Wilken et al.
Anaerobic fungi (Neocallimastigomycota) are emerging non-model hosts for biotechnology due to their wealth of biomass-degrading enzymes, yet tools to engineer these fungi have not yet been established. Here, we show that the anaerobic gut f...
Jian Zha,Xia Wu,Guoli Gong et al. Jian Zha et al.
Metabolic engineering of microbial strains for the production of flavonoids of industrial interest has attracted great attention due to its promising advantages over traditional extraction approaches, such as independence of plantation, fac...
Paulina Torres,Pedro A Saa,Joan Albiol et al. Paulina Torres et al.
Pichia pastoris is recognized as a biotechnological workhorse for recombinant protein expression. The metabolic performance of this microorganism depends on genetic makeup and culture conditions, amongst which the specific growth rate and o...
Yuya Nakamura,Shuichi Hirose,Yuko Taniguchi et al. Yuya Nakamura et al.
Plant-biosynthesised secondary metabolites are unique sources of pharmaceuticals, food additives, and flavourings, among other industrial uses. However, industrial production of these metabolites is difficult because of their structural com...
Hoang V Dinh,Patrick F Suthers,Siu Hung Joshua Chan et al. Hoang V Dinh et al.
Rhodosporidium toruloides is a red, basidiomycetes yeast that can accumulate a large amount of lipids and produce carotenoids. To better assess this non-model yeast's metabolic capabilities, we reconstructed a genome-scale model of R. torul...
Mitchell G Thompson,Luis E Valencia,Jacquelyn M Blake-Hedges et al. Mitchell G Thompson et al.
Pseudomonas putida is a promising bacterial chassis for metabolic engineering given its ability to metabolize a wide array of carbon sources, especially aromatic compounds derived from lignin. However, this omnivorous metabolism can also be...
Cyrielle Calmels,Solène Arnoult,Bassem Ben Yahia et al. Cyrielle Calmels et al.
Biopharmaceutical industrial processes are based on high yielding stable recombinant Chinese Hamster Ovary (CHO) cells that express monoclonal antibodies. However, the process and feeding regimes need to be adapted for each new cell line, a...
Yingying Chang,Baozhong Chai,Yunkun Ding et al. Yingying Chang et al.
In pharmaceutical industry, isepamicin is mainly manufactured from gentamicin B, which is produced by Micromonospora echinospora as a minor component of the gentamicin complex. Improvement of gentamicin B production through metabolic engine...
Kamran Jawed,Syed Shams Yazdani,Mattheos Ag Koffas Kamran Jawed
Recent advances in metabolic engineering enable the production of high-value chemicals via expressing complex biosynthetic pathways in a single microbial host. However, many engineered strains suffer from poor product yields due to redox im...